Company Overview
Avroxa is a technology-based company offering innovative polyoxazolines under brandname ULTROXA. As research partner we design custom-made polymers and produce high quality, well-defined poly(2-oxazoline)s, in mg up to multi-kg scale, including cGMP manufactured materials. Due to biocompatibility, non-immunogenicity, outstanding stability and processability of polyoxazolines, they find uses in many areas: polymer therapeutics, PEG-replacement, functional coatings on particles and surfaces for in vitro-diagnostics or as anti-fouling/anti bacterial coatings, hydrogels and a variety of drug delivery systems, including prodrug depots, oral tablets, nanofibers, polyplexes, antibody drug conjugates or micelles.